Variant report
Variant | nsv1014636 |
---|---|
Chromosome Location | chr3:78464695-78491410 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577082022 | chr3:78470434-78470435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184248265 | chr3:78470444-78470445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559576550 | chr3:78470445-78470446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573000079 | chr3:78470522-78470523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541847112 | chr3:78470535-78470536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146141818 | chr3:78470539-78470540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561856910 | chr3:78470544-78470545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17298420 | chr3:78470679-78470680 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544223197 | chr3:78470713-78470714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564290307 | chr3:78470744-78470745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9882111 | chr3:78470746-78470747 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs548337858 | chr3:78470751-78470752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567141663 | chr3:78470809-78470810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4350886 | chr3:78470832-78470833 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs562063885 | chr3:78470841-78470842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527934484 | chr3:78470851-78470852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568180545 | chr3:78470866-78470867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537108000 | chr3:78470869-78470870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557002140 | chr3:78470886-78470887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376914218 | chr3:78470901-78470902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547088510 | chr3:78470926-78470927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570421863 | chr3:78470928-78470929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1512491 | chr3:78470954-78470955 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs553033768 | chr3:78470955-78470956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549826289 | chr3:78471003-78471004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs4462909 | chr3:78471042-78471043 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs555116498 | chr3:78471091-78471092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189356720 | chr3:78471109-78471110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544336056 | chr3:78471115-78471116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561992618 | chr3:78471120-78471121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1512492 | chr3:78471190-78471191 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs370821387 | chr3:78471197-78471198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4542984 | chr3:78471219-78471220 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs73111843 | chr3:78471269-78471270 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs529582771 | chr3:78471301-78471302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115496699 | chr3:78471304-78471305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569505933 | chr3:78471308-78471309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76335046 | chr3:78471311-78471312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531919024 | chr3:78471343-78471344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180901291 | chr3:78471376-78471377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550449341 | chr3:78471404-78471405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570517132 | chr3:78471415-78471416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75880279 | chr3:78471423-78471424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550082095 | chr3:78471432-78471433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552887728 | chr3:78471441-78471442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566451862 | chr3:78471446-78471447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186311342 | chr3:78471482-78471483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543509901 | chr3:78471532-78471533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140184266 | chr3:78471544-78471545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555228930 | chr3:78471555-78471556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Colorectal cancer | 16912164 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:78470400-78471400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr3:78470400-78471400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr3:78470400-78471400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr3:78470400-78471600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr3:78470600-78472000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr3:78471000-78472400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:78471400-78472600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr3:78472400-78473200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr3:78473000-78473200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr3:78473200-78473400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr3:78475400-78476000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr3:78486800-78487000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr3:78487200-78490600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr3:78490600-78491200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr3:78491200-78496200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |